The Bayer Group will be celebrating its 150th anniversary in 2013 with numerous events around the world.
“Bayer can look back on a long and highly successful history as an inventor company,” explains CEO Dr. Marijn Dekkers. “What started as a small but innovative dyestuffs factory in the Barmen district of Wuppertal is now a global enterprise with more than 110,000 employees. In the past 150 years, Bayer inventions have time and again helped improve people’s quality of life. This great tradition is also our commitment to the future – entirely in line with our mission of Bayer: Science For A Better Life.”Â
To mark the anniversary, Bayer is planning a series of events and projects worldwide throughout the coming year. These will focus on the company’s employees and their families – but neighbours, customers, partners and the scientific community are also to be included in the celebrations.
“Bayer products have become indispensable to our lives,” says Dekkers. One example is the pain reliever Aspirin™, which came on the market in 1899 and remains one of Bayer’s top products to this day. Over the decades, Bayer’s researchers have developed pioneering active substances to treat infectious, tropical and cardiovascular diseases, for example. Today, pharmaceuticals research at Bayer HealthCare concentrates mainly on the fields of cardiology and haematology, oncology, women’s healthcare and diagnostic imaging.
